{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T04:15:30Z","timestamp":1773202530621,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012154","name":"Graduate Research and Innovation Projects of Jiangsu Province","doi-asserted-by":"publisher","award":["KYCX22_3718"],"award-info":[{"award-number":["KYCX22_3718"]}],"id":[{"id":"10.13039\/501100012154","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300164"],"award-info":[{"award-number":["82300164"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100183"],"award-info":[{"award-number":["82100183"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270179"],"award-info":[{"award-number":["82270179"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20230296"],"award-info":[{"award-number":["BK20230296"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20221287"],"award-info":[{"award-number":["BK20221287"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Social Development Foundation of Zhenjiang","award":["SH2022027"],"award-info":[{"award-number":["SH2022027"]}]},{"name":"Social Development Foundation of Zhenjiang","award":["SH2023009"],"award-info":[{"award-number":["SH2023009"]}]},{"name":"Research Project of Jiangsu Commission of Health","award":["M2022123"],"award-info":[{"award-number":["M2022123"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-025-01722-5","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T08:47:50Z","timestamp":1742287670000},"page":"3395-3405","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["MiR-218 Exhibits Anti-Leukemia Effects by Targeting CTNND2 in Primary Acute Erythroid Leukemia HEL Cells"],"prefix":"10.1007","volume":"83","author":[{"given":"Ming-qiang","family":"Chu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-ting","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-jie","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-mei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-jun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang-jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-dong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"issue":"11","key":"1722_CR1","doi-asserted-by":"publisher","first-page":"6256","DOI":"10.3390\/ijms25116256","volume":"25","author":"P Fernandes","year":"2024","unstructured":"Fernandes, P., Waldron, N., Chatzilygeroudi, T., Naji, N. S., & Karantanos, T. (2024). Acute erythroid leukemia: from molecular biology to clinical outcomes. International Journal of Molecular Sciences, 25(11), 6256.","journal-title":"International Journal of Molecular Sciences"},{"issue":"8","key":"1722_CR2","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.clml.2023.04.011","volume":"23","author":"C Alexander","year":"2023","unstructured":"Alexander, C. (2023). A history and current understanding of acute erythroid leukemia. Clinical Lymphoma, Myeloma & Leukemia, 23(8), 583\u2013588.","journal-title":"Clinical Lymphoma, Myeloma & Leukemia"},{"issue":"2","key":"1722_CR3","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/jha2.676","volume":"4","author":"N Cervera","year":"2023","unstructured":"Cervera, N., Guille, A., Ad\u00e9la\u00efde, J., Hospital, M.-A., Garciaz, S., Mozziconacci, M.-J., Vey, N., Gelsi-Boyer, V., & Birnbaum, D. (2023). Erythroleukemia: classification. EJHaem, 4(2), 450\u2013453.","journal-title":"EJHaem"},{"issue":"11","key":"1722_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00746-x","volume":"12","author":"KK Reichard","year":"2022","unstructured":"Reichard, K. K., Tefferi, A., Abdelmagid, M., Orazi, A., Alexandres, C., Haack, J., & Greipp, P. T. (2022). Pure (acute) erythroid leukemia: morphology, immunophenotype, cytogenetics, mutations, treatment details, and survival data among 41 Mayo Clinic cases. Blood Cancer Journal, 12(11), 147.","journal-title":"Blood Cancer Journal"},{"issue":"9","key":"1722_CR5","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.3324\/haematol.2021.280487","volume":"107","author":"H Fang","year":"2022","unstructured":"Fang, H., Wang, S. A., Khoury, J. D., El Hussein, S., Kim, D. H., Tashakori, M., Tang, Z., Li, S., Hu, Z., Jelloul, F. Z., Patel, K. P., McDonnell, T. J., Kadia, T., Medeiros, L. J., & Wang, W: (2022). Pure erythroid leukemia is characterized by biallelic TP53 inactivation and abnormal p53 expression patterns in de novo and secondary cases. Haematologica, 107(9), 2232\u20132237.","journal-title":"Haematologica"},{"issue":"12","key":"1722_CR6","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1002\/cncr.33458","volume":"127","author":"K Sasaki","year":"2021","unstructured":"Sasaki, K., Ravandi, F., Kadia, T. M., DiNardo, C. D., Short, N. J., Borthakur, G., Jabbour, E., & Kantarjian, H. M. (2021). De novo acute myeloid leukemia: a population-based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017. Cancer, 127(12), 2049\u20132061.","journal-title":"Cancer"},{"issue":"15","key":"1722_CR7","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.3390\/cancers15153941","volume":"15","author":"K Gera","year":"2023","unstructured":"Gera, K., Martir, D., Xue, W., & Wingard, J. R. (2023). Survival after Pure (Acute) erythroid leukemia in the United States: a SEER-Based Study. Cancers (Basel), 15(15), 3941.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"1722_CR8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41576-023-00662-1","volume":"25","author":"K Nemeth","year":"2024","unstructured":"Nemeth, K., Bayraktar, R., Ferracin, M., & Calin, G. A. (2024). Non-coding RNAs in disease: from mechanisms to therapeutics. Nature Reviews Genetics, 25(3), 211\u2013232.","journal-title":"Nature Reviews Genetics"},{"issue":"11","key":"1722_CR9","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1182\/blood-2016-10-697698","volume":"130","author":"JA Wallace","year":"2017","unstructured":"Wallace, J. A., & O\u2019Connell, R. M. (2017). MicroRNAs and acute myeloid leukemia: therapeutic implications and emerging concepts. Blood, 130(11), 1290\u20131301.","journal-title":"Blood"},{"issue":"1","key":"1722_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13045-019-0734-5","volume":"12","author":"Y Liu","year":"2019","unstructured":"Liu, Y., Cheng, Z., Pang, Y., Cui, L., Qian, T., Quan, L., Zhao, H., Shi, J., Ke, X., & Fu, L. (2019). Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia. Journal of Hematology & Oncology, 12(1), 51.","journal-title":"Journal of Hematology & Oncology"},{"key":"1722_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108623","volume":"112","author":"J Ma","year":"2019","unstructured":"Ma, J., Wu, D., Yi, J., Yi, Y., Zhu, X., Qiu, H., Kong, R., Lin, J., Qian, J., & Deng, Z. (2019). MiR-378 promoted cell proliferation and inhibited apoptosis by enhanced stem cell properties in chronic myeloid leukemia K562 cells. Biomedicine and Pharmacotherapy, 112, 108623.","journal-title":"Biomedicine and Pharmacotherapy"},{"key":"1722_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-019-0894-y","volume":"19","author":"LJ Tang","year":"2019","unstructured":"Tang, L. J., Sun, G. K., Zhang, T. J., Wu, D. H., Zhou, J. D., Ma, B. B., Xu, Z. J., Wen, X. M., Chen, Q., Yao, D. M., Qian, J., Ma, J. C., & Lin, J. (2019). Down-regulation of miR-29c is a prognostic biomarker in acute myeloid leukemia and can reduce the sensitivity of leukemic cells to decitabine. Cancer Cell International, 19, 177.","journal-title":"Cancer Cell International"},{"issue":"10","key":"1722_CR13","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.18632\/aging.101991","volume":"11","author":"JD Zhou","year":"2019","unstructured":"Zhou, J. D., Li, X. X., Zhang, T. J., Xu, Z. J., Zhang, Z. H., Gu, Y., Wen, X. M., Zhang, W., Ji, R. B., Deng, Z. Q., Lin, J., & Qian, J. (2019). MicroRNA-335\/ID4 dysregulation predicts clinical outcome and facilitates leukemogenesis by activating PI3K\/Akt signaling pathway in acute myeloid leukemia. Aging (Albany NY), 11(10), 3376\u20133391.","journal-title":"Aging (Albany NY)"},{"issue":"10","key":"1722_CR14","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1038\/s41375-022-01659-1","volume":"36","author":"T-J Zhang","year":"2022","unstructured":"Zhang, T.-J., Xu, Z.-J., Wen, X.-M., Gu, Y., Ma, J.-C., Yuan, Q., Lin, J., Zhou, J.-D., & Qian, J. (2022). SLIT2 promoter hypermethylation-mediated SLIT2-IT1\/miR-218 repression drives leukemogenesis and predicts adverse prognosis in myelodysplastic neoplasm. Leukemia, 36(10), 2488\u20132498.","journal-title":"Leukemia"},{"issue":"10","key":"1722_CR15","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1080\/15384101.2023.2200312","volume":"22","author":"J Ma","year":"2023","unstructured":"Ma, J., Wen, X., Xu, Z., Xia, P., Jin, Y., Lin, J., & Qian, J. (2023). Abnormal regulation of miR-29b-ID1 signaling is involved in the process of decitabine resistance in leukemia cells. Cell Cycle, 22(10), 1215\u20131231.","journal-title":"Cell Cycle"},{"issue":"6","key":"1722_CR16","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1158\/0008-5472.CAN-10-2754","volume":"71","author":"NM Alajez","year":"2011","unstructured":"Alajez, N. M., Lenarduzzi, M., Ito, E., Hui, A. B., Shi, W., Bruce, J., Yue, S., Huang, S. H., Xu, W., Waldron, J., O'Sullivan, B., & Liu, F. F. (2011). MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Research, 71(6), 2381\u20132391.","journal-title":"Cancer Research"},{"issue":"17","key":"1722_CR17","doi-asserted-by":"publisher","first-page":"5765","DOI":"10.1158\/0008-5472.CAN-11-0368","volume":"71","author":"A Uesugi","year":"2011","unstructured":"Uesugi, A., Kozaki, K.-I., Tsuruta, T., Furuta, M., Morita, K.-I., Imoto, I., Omura, K., & Inazawa, J. (2011). The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer. Cancer Research, 71(17), 5765\u20135778.","journal-title":"Cancer Research"},{"issue":"19","key":"1722_CR18","doi-asserted-by":"publisher","first-page":"6046","DOI":"10.1158\/0008-5472.CAN-13-0358","volume":"73","author":"Y Tu","year":"2013","unstructured":"Tu, Y., Gao, X., Li, G., Fu, H., Cui, D., Liu, H., Jin, W., & Zhang, Y. (2013). MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1. Cancer Research, 73(19), 6046\u20136055.","journal-title":"Cancer Research"},{"issue":"1","key":"1722_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3892\/ijmm.2015.2216","volume":"36","author":"T Wang","year":"2015","unstructured":"Wang, T., Chen, T., Niu, H., Li, C., Xu, C., Li, Y., Huang, R., Zhao, J., & Wu, S. (2015). MicroRNA-218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1. International Journal of Molecular Medicine, 36(1), 93\u2013102.","journal-title":"International Journal of Molecular Medicine"},{"issue":"1","key":"1722_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0710-z","volume":"16","author":"Y Yang","year":"2017","unstructured":"Yang, Y., Ding, L., Hu, Q., Xia, J., Sun, J., Wang, X., Xiong, H., Gurbani, D., Li, L., Liu, Y., & Liu, A. (2017). MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6\/STAT3 and negatively correlates with poor prognosis. Molecular cancer, 16(1), 141.","journal-title":"Molecular cancer"},{"issue":"11","key":"1722_CR21","doi-asserted-by":"publisher","first-page":"8455","DOI":"10.1007\/s00432-023-04750-x","volume":"149","author":"FJ Wischmann","year":"2023","unstructured":"Wischmann, F. J., Troschel, F. M., Frankenberg, M., Kemper, B., Vijaya Kumar, A., Sicking, M., Ibrahim, S. A., Kiesel, L., G\u00f6tte, M., Eich, H. T., & Greve, B. (2023). Tumor suppressor miR-218 directly targets epidermal growth factor receptor (EGFR) expression in triple-negative breast cancer, sensitizing cells to irradiation. Journal of Cancer Research and Clinical Oncology, 149(11), 8455\u20138465.","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"issue":"2","key":"1722_CR22","first-page":"916","volume":"40","author":"Q Meng","year":"2018","unstructured":"Meng, Q., Chen, Y., Lian, B., Shang, Y., & Yang, H. (2018). miR\u2011218 promotes apoptosis of SW1417 human colon cancer cells by targeting c\u2011FLIP. Oncology Reports, 40(2), 916\u2013922.","journal-title":"Oncology Reports"},{"issue":"1","key":"1722_CR23","first-page":"13","volume":"39","author":"S Tatarano","year":"2011","unstructured":"Tatarano, S., Chiyomaru, T., Kawakami, K., Enokida, H., Yoshino, H., Hidaka, H., Yamasaki, T., Kawahara, K., Nishiyama, K., Seki, N., & Nakagawa, M. (2011). miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer. International Journal of Oncology, 39(1), 13\u201321.","journal-title":"International Journal of Oncology"},{"issue":"10","key":"1722_CR24","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.4161\/cbt.29706","volume":"15","author":"H He","year":"2014","unstructured":"He, H., Hao, S.-J., Yao, L., Yang, F., Di, Y., Li, J., Jiang, Y.-J., Jin, C., & Fu, D.-L. (2014). MicroRNA-218 inhibits cell invasion and migration of pancreatic cancer via regulating ROBO1. Cancer Biology & Therapy, 15(10), 1333\u20131339.","journal-title":"Cancer Biology & Therapy"},{"key":"1722_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.gene.2017.03.022","volume":"615","author":"X Zhang","year":"2017","unstructured":"Zhang, X., Dong, J., He, Y., Zhao, M., Liu, Z., Wang, N., Jiang, M., Zhang, Z., Liu, G., Liu, H., Nie, Y., Fan, D., & Tie, J. (2017). miR-218 inhibited tumor angiogenesis by targeting ROBO1 in gastric cancer. Gene, 615, 42\u201349.","journal-title":"Gene"},{"issue":"3","key":"1722_CR26","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/leu.2012.278","volume":"27","author":"M D\u00edaz-Bey\u00e1","year":"2013","unstructured":"D\u00edaz-Bey\u00e1, M., Navarro, A., Ferrer, G., D\u00edaz, T., Gel, B., Cam\u00f3s, M., Pratcorona, M., Torrebadell, M., Rozman, M., Colomer, D., Monzo, M., & Esteve, J. (2013). Acute myeloid leukemia with translocation (8;16)(p11;p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene. Leukemia, 27(3), 595\u2013603.","journal-title":"Leukemia"},{"issue":"6","key":"1722_CR27","first-page":"8078","volume":"14","author":"Y Wang","year":"2017","unstructured":"Wang, Y., Sun, H.-H., Sui, M.-H., & Ma, J.-J. (2017). miR-218 inhibits acute promyelocytic leukemia cell growth by targeting BMI-1. Oncology Letters, 14(6), 8078\u20138083.","journal-title":"Oncology Letters"},{"issue":"1","key":"1722_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2217\/epi.11.104","volume":"4","author":"N Bianchi","year":"2012","unstructured":"Bianchi, N., Zuccato, C., Finotti, A., Lampronti, I., Borgatti, M., & Gambari, R. (2012). Involvement of miRNA in erythroid differentiation. Epigenomics, 4(1), 51\u201365.","journal-title":"Epigenomics"},{"issue":"1","key":"1722_CR29","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s13287-023-03504-3","volume":"14","author":"SM Nassiri","year":"2023","unstructured":"Nassiri, S. M., Ahmadi Afshar, N., & Almasi, P. (2023). Insight into microRNAs\u2019 involvement in hematopoiesis: current standing point of findings. Stem Cell Research & Therapy, 14(1), 282.","journal-title":"Stem Cell Research & Therapy"},{"issue":"12","key":"1722_CR30","doi-asserted-by":"publisher","first-page":"28156","DOI":"10.3390\/ijms161226088","volume":"16","author":"Y Li","year":"2015","unstructured":"Li, Y., Liu, S., Sun, H., Yang, Y., Qi, H., Ding, N., Zheng, J., Dong, X., Qu, H., Zhang, Z., & Fang, X. (2015). MiR-218 inhibits erythroid differentiation and alters iron metabolism by targeting ALAS2 in K562 cells. International Journal of Molecular Sciences, 16(12), 28156\u201328168.","journal-title":"International Journal of Molecular Sciences"},{"issue":"8","key":"1722_CR31","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1111\/jcmm.13073","volume":"21","author":"JD Zhou","year":"2017","unstructured":"Zhou, J. D., Zhang, T. J., Li, X. X., Ma, J. C., Guo, H., Wen, X. M., Zhang, W., Yang, L., Yan, Y., Lin, J., & Qian, J. (2017). Epigenetic dysregulation of ID4 predicts disease progression and treatment outcome in myeloid malignancies. Journal of Cellular and Molecular Medicine, 21(8), 1468\u20131481.","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"3","key":"1722_CR32","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3727\/096504016X14738114257367","volume":"25","author":"G Wang","year":"2017","unstructured":"Wang, G., Fu, Y., Liu, G., Ye, Y., & Zhang, X. (2017). miR-218 inhibits proliferation, migration, and EMT of gastric cancer cells by targeting WASF3. Oncology Research, 25(3), 355\u2013364.","journal-title":"Oncology Research"},{"key":"1722_CR33","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.canlet.2017.06.006","volume":"403","author":"M Deng","year":"2017","unstructured":"Deng, M., Zeng, C., Lu, X., He, X., Zhang, R., Qiu, Q., Zheng, G., Jia, X., Liu, H., & He, Z. (2017). miR-218 suppresses gastric cancer cell cycle progression through the CDK6\/Cyclin D1\/E2F1 axis in a feedback loop. Cancer Letters, 403, 175\u2013185.","journal-title":"Cancer Letters"},{"issue":"3","key":"1722_CR34","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.bbrc.2014.12.026","volume":"456","author":"G Han","year":"2015","unstructured":"Han, G., Fan, M., & Zhang, X. (2015). microRNA-218 inhibits prostate cancer cell growth and promotes apoptosis by repressing TPD52 expression. Biochemical and Biophysical Research Communications, 456(3), 804\u2013809.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"6","key":"1722_CR35","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.3892\/or.2016.5195","volume":"36","author":"Q Fu","year":"2016","unstructured":"Fu, Q., Cheng, J., Zhang, J., Zhang, Y., Chen, X., Xie, J., & Luo, S. (2016). Downregulation of YEATS4 by miR-218 sensitizes colorectal cancer cells to L-OHP-induced cell apoptosis by inhibiting cytoprotective autophagy. Oncology Reports, 36(6), 3682\u20133690.","journal-title":"Oncology Reports"},{"issue":"2","key":"1722_CR36","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3892\/etm.2020.9538","volume":"21","author":"W Tian","year":"2021","unstructured":"Tian, W., Yuan, X., Song, Y., Zhai, J., Wei, H., Wang, L., Li, D., & Chen, Q. (2021). miR-218 inhibits glucose metabolism in non-small cell lung cancer via the NF-\u03baB signaling pathway. Experimental and Therapeutic Medicine, 21(2), 106.","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"18","key":"1722_CR37","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1038\/onc.2016.414","volume":"36","author":"ZM Shi","year":"2017","unstructured":"Shi, Z. M., Wang, L., Shen, H., Jiang, C. F., Ge, X., Li, D. M., Wen, Y. Y., Sun, H. R., Pan, M. H., Li, W., Shu, Y. Q., Liu, L. Z., Peiper, S. C., He, J., & Jiang, B. H. (2017). Downregulation of miR-218 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer by targeting Slug\/ZEB2 signaling. Oncogene, 36(18), 2577\u20132588.","journal-title":"Oncogene"},{"issue":"2","key":"1722_CR38","first-page":"1821","volume":"16","author":"B Guan","year":"2018","unstructured":"Guan, B., Mu, L., Zhang, L., Wang, K., Tian, J., Xu, S., Wang, X., He, D., & Du, Y. (2018). MicroRNA-218 inhibits the migration, epithelial-mesenchymal transition and cancer stem cell properties of prostate cancer cells. Oncology Letters, 16(2), 1821\u20131826.","journal-title":"Oncology Letters"},{"issue":"5","key":"1722_CR39","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/abbs\/gmx017","volume":"49","author":"T Wang","year":"2017","unstructured":"Wang, T., Xu, L., Jia, R., & Wei, J. (2017). MiR-218 suppresses the metastasis and EMT of HCC cells via targeting SERBP1. Acta Biochimica et Biophysica SINICA, 49(5), 383\u2013391.","journal-title":"Acta Biochimica et Biophysica SINICA"},{"issue":"3","key":"1722_CR40","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.juro.2013.02.089","volume":"190","author":"T Yamasaki","year":"2013","unstructured":"Yamasaki, T., Seki, N., Yoshino, H., Itesako, T., Hidaka, H., Yamada, Y., Tatarano, S., Yonezawa, T., Kinoshita, T., Nakagawa, M., & Enokida, H. (2013). MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway. The Journal of Urology, 190(3), 1059\u20131068.","journal-title":"The Journal of Urology"},{"issue":"5","key":"1722_CR41","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.3892\/ijmm.2015.2126","volume":"35","author":"X Zhang","year":"2015","unstructured":"Zhang, X., Shi, H., Tang, H., Fang, Z., Wang, J., & Cui, S. (2015). miR-218 inhibits the invasion and migration of colon cancer cells by targeting the PI3K\/Akt\/mTOR signaling pathway. International Journal of Molecular Medicine, 35(5), 1301\u20131308.","journal-title":"International Journal of Molecular Medicine"},{"issue":"7","key":"1722_CR42","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1111\/cas.12441","volume":"105","author":"R Nishikawa","year":"2014","unstructured":"Nishikawa, R., Goto, Y., Sakamoto, S., Chiyomaru, T., Enokida, H., Kojima, S., Kinoshita, T., Yamamoto, N., Nakagawa, M., Naya, Y., Ichikawa, T., & Seki, N. (2014). Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer. Cancer Science, 105(7), 802\u2013811.","journal-title":"Cancer Science"},{"issue":"6","key":"1722_CR43","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1002\/mc.22612","volume":"56","author":"W Zhu","year":"2017","unstructured":"Zhu, W., Shao, Y., & Peng, Y. (2017). MicroRNA-218 inhibits tumor growth and increases chemosensitivity to CDDP treatment by targeting BCAT1 in prostate cancer. Molecular Carcinogenesis, 56(6), 1570\u20131577.","journal-title":"Molecular Carcinogenesis"},{"issue":"7","key":"1722_CR44","doi-asserted-by":"publisher","first-page":"691","DOI":"10.7150\/ijms.8880","volume":"11","author":"W Yuan","year":"2014","unstructured":"Yuan, W., Xiaoyun, H., Haifeng, Q., Jing, L., Weixu, H., Ruofan, D., Jinjin, Y., & Zongji, S. (2014). MicroRNA-218 enhances the radiosensitivity of human cervical cancer via promoting radiation induced apoptosis. International Journal of Medical Sciences, 11(7), 691\u2013696.","journal-title":"International Journal of Medical Sciences"},{"issue":"10","key":"1722_CR45","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1111\/1759-7714.13939","volume":"12","author":"X Chen","year":"2021","unstructured":"Chen, X., Xu, Y., Jiang, L., & Tan, Q. (2021). miRNA-218-5p increases cell sensitivity by inhibiting PRKDC activity in radiation-resistant lung carcinoma cells. Thoracic Cancer, 12(10), 1549\u20131557.","journal-title":"Thoracic Cancer"},{"issue":"3-4","key":"1722_CR46","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/jcb.29684","volume":"122","author":"H Chen","year":"2021","unstructured":"Chen, H., Cao, W., Chen, J., Liu, D., Zhou, L., Du, F., & Zhu, F. (2021). miR-218 contributes to drug resistance in multiple myeloma via targeting LRRC28. Journal of Cellular Biochemistry, 122(3-4), 305\u2013314.","journal-title":"Journal of Cellular Biochemistry"},{"issue":"3","key":"1722_CR47","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1182\/blood-2002-01-0309","volume":"101","author":"H Harigae","year":"2003","unstructured":"Harigae, H., Nakajima, O., Suwabe, N., Yokoyama, H., Furuyama, K., Sasaki, T., Kaku, M., Yamamoto, M., & Sassa, S. (2003). Aberrant iron accumulation and oxidized status of erythroid-specific delta-aminolevulinate synthase (ALAS2)-deficient definitive erythroblasts. Blood, 101(3), 1188\u20131193.","journal-title":"Blood"},{"issue":"1","key":"1722_CR48","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","volume":"142","author":"MW Hentze","year":"2010","unstructured":"Hentze, M. W., Muckenthaler, M. U., Galy, B., & Camaschella, C. (2010). Two to tango: regulation of Mammalian iron metabolism. Cell, 142(1), 24\u201338.","journal-title":"Cell"},{"issue":"3","key":"1722_CR49","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.exphem.2008.11.003","volume":"37","author":"M J\u00e4r\u00e5s","year":"2009","unstructured":"J\u00e4r\u00e5s, M., Johnels, P., Agerstam, H., Lassen, C., Rissler, M., Ed\u00e9n, P., Cammenga, J., Olofsson, T., Bjerrum, O. W., Richter, J., Fan, X., & Fioretos, T: (2009). Expression of P190 and P210 BCR\/ABL1 in normal human CD34(+) cells induces similar gene expression profiles and results in a STAT5-dependent expansion of the erythroid lineage. Experimental Hematology, 37(3), 367\u2013375.","journal-title":"Experimental Hematology"},{"key":"1722_CR50","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.exphem.2023.06.002","volume":"124","author":"J Artus","year":"2023","unstructured":"Artus, J., Zenych, A., Simanic, I., Desterke, C., Clay, D., Sa\u00efm, S., Ijjeh, Y., de Souza, L. E. B., Coignard, S., Bennaceur-Griscelli, A., Turhan, A. G., & Foudi, A: (2023). BCR-ABL promotes hematopoietic stem and progenitor cell formation in embryonic stem cells. Experimental Hematology, 124, 22\u201335.e3.","journal-title":"Experimental Hematology"},{"issue":"25","key":"1722_CR51","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.1182\/blood.2021014465","volume":"139","author":"B Li","year":"2022","unstructured":"Li, B., An, W., Wang, H., Baslan, T., Mowla, S., Krishnan, A., Xiao, W., Koche, R. P., Liu, Y., Cai, S. F., Xiao, Z., Derkach, A., Iacobucci, I., Mullighan, C. G., Helin, K., Lowe, S. W., Levine, R. L., & Rampal, R. K. (2022). BMP2\/SMAD pathway activation in JAK2\/p53-mutant megakaryocyte\/erythroid progenitors promotes leukemic transformation. Blood, 139(25), 3630\u20133646.","journal-title":"Blood"},{"key":"1722_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2024.104178","volume":"132","author":"TB Collins","year":"2024","unstructured":"Collins, T. B., Laranjeira, A. B. A., Kong, T., Fulbright, M. C., Fisher, D. A. C., Sturgeon, C. M., Batista, L. F. Z., & Oh, S. T. (2024). Altered erythropoiesis via JAK2 and ASXL1 mutations in myeloproliferative neoplasms. Experimental Hematology, 132, 104178.","journal-title":"Experimental Hematology"},{"key":"1722_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-9-304","volume":"9","author":"J-P Lu","year":"2010","unstructured":"Lu, J.-P., Zhang, J., Kim, K., Case, T. C., Matusik, R. J., Chen, Y.-H., Wolfe, M., Nopparat, J., & Lu, Q. (2010). Human homolog of Drosophila Hairy and enhancer of split 1, Hes1, negatively regulates \u03b4-catenin (CTNND2) expression in cooperation with E2F1 in prostate cancer. Molecular Cancer, 9, 304.","journal-title":"Molecular Cancer"},{"issue":"2","key":"1722_CR54","first-page":"809","volume":"39","author":"F Huang","year":"2018","unstructured":"Huang, F., Chen, J., Wang, Z., Lan, R., Fu, L., & Zhang, L. (2018). \u03b4-Catenin promotes tumorigenesis and metastasis of lung adenocarcinoma. Oncology Reports, 39(2), 809\u2013817.","journal-title":"Oncology Reports"},{"issue":"4","key":"1722_CR55","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1158\/1535-7163.MCT-18-0138","volume":"18","author":"T Shimizu","year":"2019","unstructured":"Shimizu, T., Ishida, J., Kurozumi, K., Ichikawa, T., Otani, Y., Oka, T., Tomita, Y., Hattori, Y., Uneda, A., Matsumoto, Y., & Date, I. (2019). \u03b4-Catenin promotes bevacizumab-induced glioma invasion. Molecular Cancer Therapeutics, 18(4), 812\u2013822.","journal-title":"Molecular Cancer Therapeutics"},{"issue":"10","key":"1722_CR56","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1016\/j.humpath.2014.05.014","volume":"45","author":"JY Zhang","year":"2014","unstructured":"Zhang, J. Y., Bai, C. Y., Bai, Y. Q., Zhang, J. Y., Wu, Z. Y., Wang, S. H., Xu, X. E., Wu, J. Y., Zhu, Y., Rui, Y., Li, E. M., & Xu, L. Y: (2014). The expression of \u03b4-catenin in esophageal squamous cell carcinoma and its correlations with prognosis of patients. Human Pathology, 45(10), 2014\u20132022.","journal-title":"Human Pathology"},{"issue":"11","key":"1722_CR57","doi-asserted-by":"publisher","first-page":"a011254","DOI":"10.1101\/cshperspect.a011254","volume":"4","author":"DK Morrison","year":"2012","unstructured":"Morrison, D. K. (2012). MAP kinase pathways. Cold Spring Harbor Perspectives in Biology, 4(11), a011254.","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"issue":"3","key":"1722_CR58","first-page":"1997","volume":"19","author":"Y-J Guo","year":"2020","unstructured":"Guo, Y.-J., Pan, W.-W., Liu, S.-B., Shen, Z.-F., Xu, Y., & Hu, L.-L. (2020). ERK\/MAPK signalling pathway and tumorigenesis. Experimental and Therapeutic Medicine, 19(3), 1997\u20132007.","journal-title":"Experimental and Therapeutic Medicine"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01722-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-025-01722-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01722-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T23:58:51Z","timestamp":1757203131000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-025-01722-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":58,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["1722"],"URL":"https:\/\/doi.org\/10.1007\/s12013-025-01722-5","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]},"assertion":[{"value":"7 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The present study approved by the Ethics Committee of The Affiliated People\u2019s Hospital of Jiangsu University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"This final version of this manuscript has been approved by all co-authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}